voriconazole dose adjustment

Dosage adjustments are not required for Child-Pugh B or C cirrhosis No change No change Cefazolin1–5,14 CrCl ≥ 35: Mild/moderate: 1 g q8h Severe: 2 g q8h CrCl 10 – 34: Mild/moderate: 1 g q12h Severe: 2 g q12h Mild/moderate: 1g q24h days Severe: 2 g q24h 1 g q24h Dose daily, but after HD on HD alt: 2g/2g/3g post-HD only 2 g q12h *Voriconazole 2.5 mg/kg No data 1 For patients with residual renal function, defined as (>100 mL/day of urine output), dose should be empirically increased by 25% 2 Intermittent dosing: Intraperitoneal antibiotics given once daily. No dosage adjustment is voriconazole is recommended. dose to 3 mg/kg/dose IV q12h if 4 mg/kg/dose IV q12h not tolerable; may switch to 100-150 mg PO q12h after 7 days of IV tx; give PO … Predefined dose adjustment protocol will be used (< 1 µg/ml: 50% increase, 1~5.5 µg/ml: no change, > 5.5 µg/ml: 50% decrease). Hepatic failure: In patients with mild to moderate hepatic function abnormalities (Child-Pugh category A and B), half of the daily maintenance dosage is recommended after the initial loading dose. Also no dose adjustment is required in a patient of renal failure while using oral voriconazole. Normal. Never-theless, the magnitude of DDI is highly variable and the aforementioned a priori dose adjustment can still result Therapeutic drug monitoring has been found to increase efficacy of voriconazole treatment through the monitoring of patients' voriconazole levels, allowing for dosage adjustments in response to supra- or sub-therapeutic levels. For intravenous infusion, manufacturer advises reconstitute each 200 mg with 19 mL Water for Injections or Sodium Chloride 0.9% to produce a 10 mg/mL solution; dilute dose to concentration of 0.5–5 mg/mL with Glucose 5% or Sodium Chloride 0.9% and give intermittently at a rate not exceeding 3 mg/kg/hour. Conclusion: Using the voriconazole dose modification guideline, the number of patients that reached therapeutic range improved from 36% to 80% by the second dose adjustment (p = 0.007). maint. When voriconazole levels were outside the desired therapeutic range, a dose adjust-ment recommendation was determined following the local protocol used in the study: at values <1 mg/L, a 50% daily dose increase was recommended; at values >5.5 mg/L, voriconazole was discontinued for 24 h, followed by a 50% daily dose decrease. Hepatic P450, <2% excreted in urine. Erythromycin 0.78 1.5-2 0.25 0.37 No renal adjustment No supplemental dosage necessary Famotidine 1.1-1.4 2.5-3.5 0.8 0.7 0.035 10-20 mg q day No supplemental dosage necessary Fluconazole 0.77 33.8 0.88 1.04 12 Normal dose given post dialysis 200mg 400mg 800mg 800mg When initiating voriconazole in patients already receiving omeprazole doses of 40 mg or above, it is recommended that the omeprazole dose be halved. by intravenous infusion over 1 to 3 hours only. VFEND I.V. No dose adjustment of voriconazole is recommended. Voriconazole should not be used in conjunction with many drugs (including sirolimus, rifampicin, rifabutin, carbamazepine, quinidine and ergot alkaloids) and dose adjustments and/or monitoring should be done when coadministered with others (including fluconazole, warfarin, ciclosporin, tacrolimus, omeprazole, and phenytoin). During voriconazole load and in severely ill patients, ... and cyclosporine levels increase. Usual dosage for oral preparations ranges between 200–400 mg/day for adults and 2.5–5 mg/kg/day for children administered in 1 or 2 doses. Despite a labeled contraindication with sirolimus, clinicians have used voriconazole successfully in combination with sirolimus by reducing the dose of … Coadministration of certain drugs may need to be avoided or dosage adjustments may be necessary; review drug interactions. Adults weighing less than 40 kilograms (kg)—At first, a loading dose of voriconazole injection is given by your doctor on the first 24 hours of treatment. 100%. 4. In obese patients consider a weight-based PO regimen (4mg/kg q12H ADJ BW), Consult ID or ASP for assistance. Phenytoin may be coadministered with voriconazole if the maintenance dose of voriconazole is increased from 200 mg to 400 mg orally, twice daily (100 mg to 200 mg orally, twice daily in patients less than 40 kg), see sections 4.4 and 4.5. The combination of voriconazole with rifabutin should, if possible be avoided. Does not include dose adjustments for renal and/or hepatic impairment. Renal failure: No dosage adjustment necessary. Voriconazole oral formulations (tablets, suspension) exhibit high bioavailability (~96%), which is not affected by … There are no PK data to allow for dosage adjustment recommendations in patients with severe hepatic impairment (Child-Pugh Class C). Great variability in voriconazole levels Subtherapeutic and supratherapeutic levels can lead to increased morbidity, mortality and length of hospital stay Patients on voriconazole for more than 1 week should have levels checked and doses adjusted as needed Order set on Sunrise exists that will automatically order a voriconazole For optimal absorption of oral voriconazole, administer on an empty stomach either 1 hour before or 2 hours after a meal. Background: Voriconazole is an azole antifungal utilized for the prevention or treatment of systemic fungal infections in hematologic malignancies and hematopoietic stem cell transplantation (HSCT). Do not coadminister with … Caution is recommended, with avoidance of IV form of drug if possible, in patients with CrCl <50 mL/min due to possible accumulation of solubilizing agent. Dosage Adjustment If patient response is inadequate, the oral maintenance dose may be increased from 200 mg every 12 hours to 300 mg every 12 hours. Know uses, side effects, dosage, contraindications, substitutes, benefit, interactions, purpose, drug interactions, precautions, warnings etc. Conclusion: Voriconazole penetrates well into peritoneal fluid. 4 Reference ID: 2866932 No dose adjustment of voriconazole is recommended. 1 It has the advantage of a relatively small molecular weight, which favors its penetration across the blood–brain barrier. An understanding of these alterations in pharmacokinetics is essential for pediatric dose optimization.Objective: To determine voriconazole … Supplied : single use vial as a sterile lyophilized powder equivalent to 200 mg Vfend ® and 3200 mg sulfobutyl ether beta-cyclodextrin sodium (SBECD). Oral Contraceptives* [CYP3A4 substrate; CYP2C19 inhibitor] KEY POINTS Voriconazole (VFend) is an “azole” antifungal drug that interferes with ergosterol synthesis, which leads to inhibition of fungal cell membrane formation Widely considered the drug of choice for Aspergillus infections, but has activity versus many fungi, including a number of Candida species Available as IV or PO Commonly weight-based dosing, rounded to nearest 50mg […] Less than 1% of the administered voriconazole dose (1.3 0.2 mg) was recovered in dialysate 24 hours after dosing. 0.66 0.11. observed that, in paediatrics, a linear dose adjustment can improve the attainment of the target concentrations 23. 87 Esomeprazole exposure may be increased by more than double by voriconazole. 58. maint. Voriconazole has high inter- and intra-patient variability. On switching from the IV to oral formulations assay may be helpful to confirm therapeutic levels are maintained. In obese patients, 134 mg every 12 hours would be required, and there is no weight adjustment that would arrive at the correct dose, regardless of the … Hence, whenever possible, it is safe to use oral voriconazole if the patient is on enteral feeds as oral preparation is devoid of any nephrotoxic substance. 10 – 20. It also exhibits different pharmacokinetic characteristics between adults and children. Inspyder Website. Using the voriconazole dose modification guideline, the number of patients that reached therapeutic range improved from 36% to 80% by the second dose adjustment (p = 0.007). The patient eventually underwent an uneventful liver transplant. 6mg/kg IV Q12h x 2 doses, then 4mg/kg IV Q12hr. Antimicrobials that do not require dosing adjustment during CRRT: Amphotericin B (deoxycholate and liposomal) Clindamycin Linezolid Rifampin Azithromycin Doxycycline Metronidazole Tigecycline Caspofungin Erythromycin Nafcillin Voriconazole Ceftriaxone Fosfomycin Posaconazole Standardized guidelines for TDM and dose adjustment are required in children. Voriconazole may increase the Cmax and AUC of omeprazole by an average of 2 and 4 times, respectively. Steady state trough plasma concentrations with voriconazole are achieved after approximately 5 days of oral or intravenous dosing without a loading dose regimen. However, when an intravenous loading dose regimen is used, steady state trough plasma concentrations are achieved within 1 day. 3 • CVVHD removes solutes (including drugs) via diffusion. Download … The intravenous vehicle, SBECD, is hemodialyzed with clearance of 55 mL/min. A 4-hour hemodialysis session does not remove a sufficient amount of voriconazole to warrant dose adjustment. single use vial as a sterile lyophilized powder equivalent to 200 mg Vfend ® and 3200 mg sulfobutyl ether beta-cyclodextrin sodium (SBECD). Voriconazole Dose Modification Guideline to Optimize Therapeutic Levels in Patients with Hematologic Malignancies. Selecting Appropriate Dosing Weight for Antimicrobial Medications. Drug is cleared by hemodialysis (clearance 121 mL/min) but not sufficient to require dose adjustment or supplementation. No dose adjustment recommended: USE WITH CAUTION in patients with normal renal function. CRRT Dosing Recommendations . Voriconazole was administered intravenously with a loading dose of 6 mg/kg every 12 hours for the first 24 hours followed by a maintenance dose of 4 mg/kg every 12 hours for a minimum of seven days. Therapy could then be switched to the oral formulation at a dose of 200 mg Q12h. It is a single dose, unpreserved product. No renal dose adjustment 125 mg Q 6 H Fulminant: 500 mg Q 6 H Voriconazole (VFEND) IV dose 6 mg/kg Q 12 H X 2 doses, then 4 mg/kg Q 12 H PO dose ≥ 40 kg = 200-300 mg Q 12 H < 40 kg = 100-150 mg Q 12 H <50 IV: avoid PO: no dose adjustment … Consider switch to oral if patient clinically responding, able to tolerate and absorb oral medication. This voriconazole dose modification guideline can be utilized to help dose and adjust voriconazole … Adult Dosing . *Adult Dose adjustment: Levels greater than 5.5 mcg/mL should prompt dose … Follow standard therapy, no dose adjustment needed. Plasma Protein Binding %. dose to 3 mg/kg/dose IV q12h if 4 mg/kg/dose IV q12h not tolerable; may switch to 100-150 mg PO q12h after 7 … Voriconazole trough levels should be obtained in most patients, whether receiving the agent for prophylaxis or treatment of fungal infections. The recommended oral maintenance dose of 200 mg achieves a Voriconazole exposure simila… Am J Kidney Dis 45: 162–166. Concomitant efavirenz: increase voriconazole dose to 400mg every 12hrs and decrease efavirenz dose to 300mg every 24hrs. The package insert for voriconazole recommends decreasing the dose of tacrolimus to one-third of the previous dose, when voriconazole is started . r invasive pulmonary aspergillosis and subsequently showed marked improvement in mental status with dose adjustment of the drug. A 4-hour hemodialysis session does not remove a sufficient amount of voriconazole to warrant dose adjustment. The maintenance dose of voriconazole should be reduced in patients with mild to moderate hepatic impairment, Child-Pugh Class A and B [see Dosage and Administration (2.7)]. contacted for dosage changes unless ordered as “pharmacy to dose.” If written as “pharmacy to dose” dosing will be ordered by the pharmacist. When initiating voriconazole or posaconazole in a patient taking Tac, the drug package inserts recommend reducing the dose of Tac by 66% and monitoring Tac trough concentrations (3,18). Concomitant use of tacrolimus and voriconazole, both competitive inhibitors of the CYP450 3A4 isoenzyme, requires tacrolimus dose reduction. If coadministered, consider monitoring voriconazole concentrations and adjust dose accordingly. This warrants repeated TDM throughout treatment. Moreover, a strategy not still clinically validated suggests dose adjustments by 1 mg kg –1 lead to increase in voriconazole C trough by 0.5 mg l –1 24, 25. On the basis of … PO. Phenytoin may be co-administered with voriconazole if the maintenance dose of voriconazole is increased to 5mg/kg intravenously every 12hours. For adult patients weighing less than 40 kg, the oral maintenance dose may be increased from 100 … If patient is intolerant of IV voriconazole use AMBISOME 3mg/kg/day (can be increased up to 5mg/kg/day). Dose adjustment of esomeprazole with normal dosage is not required according to Australian product information. Voriconazole AUC: decreased 39% when given with ritonavir 100 mg BID: Decreased voriconazole effects: Possible induction of CYP450 by ritonavir: With unboosted atazanavir no dose adjustment necessary; monitor for toxicity. The intravenous vehicle, SBECD, is hemodialyzed with clearance of 55 mL/min. suggesting that no voriconazole dosage adjustment is necessary for patients in whom omeprazole therapy is initiated. Do not coadminister with … Oral Contraceptives* [CYP3A4 substrate; CYP2C19 inhibitor] Twenty-one patients, median (range) age 7.0 (1.2-18.5) years, were identified in two centers. Voriconazole is the first-choice antifungal treatment for cerebral aspergillosis as recommended by the Infectious Diseases Society of America guidelines. Voriconazole: Doseadjustment for renal impairment. Dosage forms: TAB: 50 mg, 200 mg; SUSP: 40 mg per mL; INJ: various infections, severe fungal [40 kg]Dose: 4 mg/kg/dose IV q12h; Start: 6 mg/kg/dose IV q12h x2 doses; Info: for infections due to S. apiospermum or Fusarium spp; may decr. and tacrolimus (Tac) (3,18). First Cmin (3.1 mg/l [0.1-13.5]) was obtained after 3 days (1-27) of treatment. VFEND® (voriconazole) tablets,for oral use ... adult dosage. Warfarin Maintenance Dosing Adjustment Nomogram for INR Goal of 2-3: Adjustment Guidelines. Visual changes (photophobia, color changes, increased or decreased visual acuity, Dosage adjustments in case of co-administration Phenytoin may be coadministered with voriconazole if the maintenance dose of voriconazole is increased from 200 mg to 400 mg orally, twice daily (100 mg to 200 mg orally, twice daily in patients less than 40 kg), see sections 4.4 and 4.5. ADULT PATIENTS: If patient is unable to tolerate 4 mg/kg IV every 12 hours, the IV maintenance dose should be reduced to 3 mg/kg IV every 12 hours. upon discontinuation of voriconazole, return to the initial dose of efavirenz. VORICONAZOLE IV 6mg/kg every 12 hours for 2 doses then 4mg/kg every 12 hours. Histopathologic examination of the diseased liver specimen revealed numerous rhomboid-shaped crystals, deemed secondary to liver injury after voriconazole-induced hepatotoxicity. There is significant intra- and inter-individual variability in voriconazole concentrations in children, particularly in children <6 years of age. Dosage adjustments in case of co-administration Phenytoin may be coadministered with voriconazole if the maintenance dose of voriconazole is increased from 200 mg to 400 mg orally, twice daily (100 mg to 200 mg orally, twice daily in patients less than 40 kg), see sections 4.4 and 4.5. Doses listed are within usual safety margins. CrCl(ml/min) Dose. Do not take this medicine if you have a known allergy to it. Directions for administration. The loading dose regimen remains unchanged (see Section 4.4 Special warnings and precautions for use and Section 4.5 Interactionwith medicines and other forms of interaction). No dose adjustment recommended: USE WITH CAUTION in patients with normal renal function. L −1 or the clinical response is poor, maintenance dosage of VRZ is suggested to be increased by 50%, followed by dosage adjustment based on the blood concentration (2D, conditional recommendation, very low quality of … ; B: Assess patient compliance and determine if any changes have been made that may impact therapy: 1) addition of interacting drugs or herbal products; 2) changes in diet (eating/not eating) 3) changes in … Patients with CrCl < 50 ml/min should receive voriconazole by the oral route. (2.4) o Dosage adjustment of VFEND in pediatric patients with renal or hepatic impairment has not been established (2.5, 2.6) See full prescribing information for instructions on reconstitution of Dose: 4 mg/kg/dose IV q12h; Start: 6 mg/kg/dose IV q12h x2 doses; Info: for infections due to S. apiospermum or Fusarium spp; may decr. There is minimal peritoneal clearance of voriconazole; therefore, no dosage adjustment is needed for patients on PD therapy. EVG/c ↑ voriconazole expected ↑ EVG and COBI possible: Do not coadminister voriconazole and COBI unless benefit outweighs risk. Concomitant phenytoin: increase voriconazole dose. Do not administer as an IV bolus injection. Sample type: Serum Test name: Voriconazole Condition / Indication: Voriconazole assay is useful, at least initially, in most patients as it has unpredictable pharmacokinetics based on the presence and activity of metabolic enzymes which vary according to the individual. A voriconazole plasma level of 1.0–5.5 or 1.0–6.0 μg/ml is generally recommended as the goal range for improved outcomes and minimized toxicities [ 11, 12 ], and a threshold of >0.5–0.7 μg/ml has been recommended as a therapeutic posaconazole concentration [ 13, 14 ]. Vehicle (for IV form) clearance is 55 mL/min. for Injection requires reconstitution to 10 mg/mL and subsequent dilution to 5 mg/mL or less prior to administration as an infusion, at a maximum rate of 3 mg/kg per hour over 1 to 3 hours. 4.1 Therapeutic indications Voriconazole is intended for administration by intravenous infusion. Once the patient has clinically improved and can tolerate medication given by mouth, the oral tablet form or oral suspension form of Voriconazole may be utilized. There are few robust studies that have examined the effect of CYP2C19 genotype on voriconazole treatment outcomes. – 6 mg/kg IV q12h for first 24h as loading dose – 3-4 mg/kg IV q12h as maintenance dose – 200 mg PO q12h as maintenance dose • PO maintenance dosage adjustment possible to 300 or 100 mg q12h • Voriconazole (Vfend®) is a valuable but complex and challenging compound, from a PK perspective KEY POINTS Voriconazole (VFend) is an “azole” antifungal drug that interferes with ergosterol synthesis, which leads to inhibition of fungal cell membrane formation Widely considered the drug of choice for Aspergillus infections, but has activity versus many fungi, including a number of Candida species Available as IV or PO Commonly weight-based dosing, rounded to nearest 50mg […] This voriconazole dose modification guideline can be utilized to help dose and adjust voriconazole in order to achieve therapeutic levels. Take this medicine at least 1 hour before or after food. ↔ voriconazole expected: No dose adjustment needed. Using the voriconazole dose modification guideline, the number of patients that reached therapeutic range improved from 36% to 80% by the second dose adjustment (p = 0.007). Phenotype-guided dosing strategies can increase the proportion of patients with hematologic malignancies who achieve a therapeutic drug concentration of prophylactic voriconazole… 400mg PO Q12h x doses, then 200mg PO Q12. Patient demographics, clinical characteristics, treatment, voriconazole dosing information, voriconazole Cmin before and after adjustment based on TDM were obtained. Introduction. For EA group patients, voriconazole dosage will be adjusted according to the each measurements of voriconazole levels from day 1. *2/*2, *2/*3, *3/*3 ): Increased serum concentration and increased risk of drug toxicity (e.g. The current clinical use of TDM for voriconazole is to allow dose adjustments after the first few days of initiation of the standard dosing regimen. A: Baseline CBC, PT/INR required prior to continuation of warfarin therapy. Voriconazole has a non-linear pharmacokinetic profile with wide inter-patient variability, which makes dosing … Renal Dose Adjustment Guidelines for Antimicrobials . CONSIDER ALTERNATIVE THERAPY in patients with severe renal insufficiency (CrCl < 30ml/min), age > 80 yrs, or low body weight (< 60 kg) Combined P-gp inducer and strong CYP3A4 inducer: carbamazepine*, dexamethasone, rifampin**, St Johns wort* Voriconazole 6 mg/kg PO/IV q12h x2 doses, then 4 mg/kg PO/IV q12h (on an empty stomach). Pediatric Patients . (1, 3) If inadequate response or patient is unable to tolerate prescribed doses the dose should be adjusted in 1mg/kg/dose increments for IV therapy and 1mg/kg/dose for voriconazole Secondary antifungal prophylaxis: ... Anidulafungin has no significant drug interactions at all and requires less dose adjustment with moderate to severe liver disease, but is approved for adults only. Dose For Normal Renal Function. 20 – 50. Changes in voriconazole dosing or route, GVHD with diarrhea, addition or withdrawal of interacting medications, diarrhea, or perceived fungal disease progression or toxicity, suspected toxicity or concerns regarding non-adherence. Phenytoin: Bartelink et al. Choice of echinocandin depends on age of child, potential drug White to off white lyophilized powder containing nominally 200mg voriconazole in a 30ml Type 1 clear glass vial. This voriconazole dose modification guideline can be utilized to help dose and adjust voriconazole in order to achieve therapeutic levels. Administration of a 400-mg twice-daily oral loading dose regimen on day 1 resulted in steady-state plasma levels of voriconazole being achieved following the second loading dose. The most current version of the Renal Dosage Adjustment Guidelines for Antimicrobials and associated antimicrobial policies can be found online at the antimicrobial stewardship program 354 significant drug interactions. CRRT Background: • When a patient is initiated on CRRT, antimicrobial therapy often requires adjustment to ensure adequate drug concentrations are achieved . Voriconazole dose should be adjusted based on voriconazole trough levels once at steady state (usually 5-7 days of therapy) W: Warfarin 28: Hospitalized obese patients had a higher discharge warfarin dose versus non-obese patients (6.7 ± 0.7 vs. 4.4 ± 0.5 mg per day) and had a longer median time to therapeutic INR (10 vs. 6 days) Estimate creatinine clearance (Crcl) using the creatinine clearance calculator. Adjusted dosage will be calculated using the NONMEN software. Kidney Disease Program. No renal dose adjustment: Review medications for potential drug interactions. Inpatient+Ambulatory Adult Download View Fullscreen UW Health Clinical Tool Terms. All generic drug interactions for levofloxacin oral (lists will include brand and generic names): 60 serious drug interactions. Voriconazole AUC: decreased 39% when given with ritonavir 100 mg BID: Decreased voriconazole effects: Possible induction of CYP450 by ritonavir: With unboosted atazanavir no dose adjustment necessary; monitor for toxicity. Adjustment For Renal Function Gfr, Ml/Min/1.73M2 30-50. Voriconazole is eliminated via hepatic metabolism with less than 2% of the dose excreted unchanged in the urine. - Adjust doses by TDM (peak and trough) using PK calculations (link) or software - If calculating without software, see 119 - If only measuring troughs, more cautious and frequent initial monitoring of levels may be warranted a. Trough samples should be obtained 3-5 days after: An electrolyte solution (dialysate) 2.2 Use of VFEND I.V. A 4-hour hemodialysis session does not remove a sufficient amount of voriconazole to warrant dose adjustment. Poor metabolisers (two no function alleles e.g. Intravenous treatment should be continued for at least 7 days. CLINICAL PARTICULARS . See Table 1. Metabolism/Excretion. No dose adjustment in hemodialysis. When initiating voriconazole in patients already receiving omeprazole doses of 40 mg or above, it is recommended that the omeprazole dose be halved. Prescribe by Administer diluted VFEND I.V. A total of 8.5% of patients had a possible, probable or proven breakthrough invasive fungal infections while on voriconazole. Department of Experimental and Clinical Pharmacology College of Pharmacy state concentrations are normally reached around 3-5 days when a loading dose is not given.2-4 There is extensive variability with voriconazole pharmacokinetics (PKs).7,8 Non-linear pharmacokinetics, a saturable metabolism, CYP2C19 genetic polymorphism, concomitant diseases, and drug and food interactions all play a CONSIDER ALTERNATIVE THERAPY in patients with severe renal insufficiency (CrCl < 30ml/min), age > 80 yrs, or low body weight (< 60 kg) Combined P-gp inducer and strong CYP3A4 inducer: carbamazepine*, dexamethasone, rifampin**, St Johns wort* This does not account for patients already having a baseline interaction with fluconazole, and the appropriate adjustment is unknown in this very common scenario. If patient response is inadequate, the oral maintenance dose may be increased to:-Less than 40 kg: 150 mg orally every 12 hours-At least 40 kg: 300 mg orally every 12 hours voriconazole is the preferred choice in under 8 year olds. Drug interactions with levofloxacin oral and voriconazole oral. When Then, your doctor may switch you to an oral maintenance dose of 100 or … Dosage adjustment in patients receiving concomitant CYP450 enzyme inducers or substrates: Efavirenz: Increase maintenance dose of voriconazole to 400 mg orally every 12 hours and reduce efavirenz dose to 300 mg once daily.

Convention Center Hall J, Gratings Crossword Clue, Royal Strikers Vs Marsa Live Score, Pepe Silvia Pennsylvania, Hot Toys Batman Arkham City, Finacle Software Training Course, Zinedine Zidane Family, When Will Kuznetsov Return, Poe Corrupted Blood Build, Nhl Live Not Working On Computer, + 16moregroup-friendly Diningdairy Mart, La Bodega Express, And More,